1. Articles mentioning both Duke University and FDA

    1-24 of 27 1 2 »

    2. Weakly supervised individual ganglion cell segmentation from adaptive optics OCT images for glaucomatous damage assessment

      Explore OSA | OSA Publishing Ophthalmology
      Weakly supervised individual ganglion cell segmentation from adaptive optics OCT images for glaucomatous damage assessment
      Cell-level quantitative features of retinal ganglion cells (GCs) are potentially important biomarkers for improved diagnosis and treatment monitoring of neurodegenerative diseases such as glaucoma, Parkinsons disease, and Alzheimers disease. Yet, due to limited resolution, individual GCs cannot be visualized by commonly used ophthalmic imaging systems, including optical coherence tomography (OCT), and assessment is limited to gross layer thickness analysis. Adaptive optics OCT (AO-OCT) enables in vivo imaging of individual retinal ...
      Read Full Article
      Mentions: Duke University FDA Indiana University

    4. Consolidation of Imaging Modalities Utilizing Digitally Assisted Visualization Systems: The Development of a Surgical Information Handling Cockpit

      Explore Medical Journals Publisher Ophthalmology
      Consolidation of Imaging Modalities Utilizing Digitally Assisted Visualization Systems: The Development of a Surgical Information Handling Cockpit
      ...ncept for the vitreoretinal operating room – a DAVS-based surgical information handling cockpit – integrating FDA approved ocular endoscopy (n=1), microscope-integrated iOCT units (n=3), and one EHR/Image management solu...
      Read Full Article
      Mentions: Duke University FDA University of Cincinnati

    15. Optical Coherence Tomography/Bioimaging: One decade and $500M: The impact of federal funding on OCT—Part 1

      Explore BioOptics World Funding
      Optical Coherence Tomography/Bioimaging: One decade and $500M: The impact of federal funding on OCT—Part 1
      ...ude Medical (which currently has the only FDA-approved product), Volcano Corp., and Terumo. LightLab received FDA clearance in 2010 and shortly afterward was acquired by St. Jude Medical for approximately $90M. Already, ...
      Read Full Article
      Mentions: National Cancer Institute Massachusetts Institute of Technology National Institutes of Health
    25. 1-24 of 27 1 2 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. Organizations in the News

    1. (10 articles) National Institutes of Health
    2. (5 articles) National Eye Institute
    3. (4 articles) Massachusetts General Hospital
    4. (3 articles) UC Irvine
    5. (3 articles) University of Miami
    6. (2 articles) Institute of Applied Physics
    7. (2 articles) University of Illinois at Urbana-Champaign
    8. (2 articles) University of Texas at Austin
    9. (2 articles) Massachusetts Institute of Technology
    10. (2 articles) Nicolaus Copernicus University
    11. (2 articles) University of Toronto
    12. (2 articles) National Research Council Canada

  5. OCT Companies in the News

    1. (11 articles) Leica
    2. (5 articles) Oncoscope
    3. (4 articles) Abbott
    4. (3 articles) Carl Zeiss Meditec
    5. (3 articles) Terumo Corporation
    6. (3 articles) NinePoint Medical
    7. (2 articles) Santec
    8. (2 articles) Optopol Technology
    9. (2 articles) Heidelberg Engineering
    10. (2 articles) Tomey Corporation
    11. (2 articles) Volcano Corporation
    12. (2 articles) Optos